Skip to main content
. 2020 Feb 19;6(3):207–213. doi: 10.1016/j.jdcr.2019.12.015

Supplemental Table II.

Clinical demographics and treatment outcomes

No. Age (yr) Sex Ethnicity Medical history Treatment regimen Treatment outcome
1 54 Female Hispanic Hypothyroidism Triamcinolone 0.1% cream
3-wk prednisone taper (60 mg: 40:20)
5-mo isotretinoin taper (40 mg: 20:20:20:10)
Complete resolution but with mild relapse after 16 mo
2 47 Female Hispanic None Halobetasol 0.05% ointment
3-wk prednisone taper (60 mg: 40:20)
4-mo isotretinoin taper (40 mg: 20:20:10)
Marked clinical improvement without recurrence at 24 mo
3 54 Female Hispanic Sjogren syndrome, fibromyalgia Halobetasol 0.05% ointment
3-wk prednisone taper (60 mg: 40:20)
3-mo isotretinoin taper (20 mg: 20:10)
Marked clinical improvement but with subjective recurrence at 2 mo
4 54 Female Hispanic DM II, HTN Halobetasol 0.05% ointment
3-wk prednisone taper (60 mg: 40:20)
1-mo isotretinoin, 20 mg/d
Complete resolution without recurrence at 2 mo

DM, Diabetes mellitus; HTN, hypertension.